Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort (2022)
- Authors:
- USP affiliated authors: SILVA, VIVIAN HELENA IIDA AVELINO DA - FM ; KALIL FILHO, JORGE ELIAS - FM ; KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.3389/fimmu.2022.908398
- Subjects: VACINAS VIRAIS; ADULTOS; INFLUENZA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 13, article ID 908398, 9p, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SILVEIRA, Cassia G. T. et al. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.908398. Acesso em: 28 abr. 2024. -
APA
Silveira, C. G. T., Magnani, D. M., Costa, P. R., Silva, V. H. I. A. da, Ricciardi, M. J., Timenetsky, M. do C. S. T., et al. (2022). Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.908398 -
NLM
Silveira CGT, Magnani DM, Costa PR, Silva VHIA da, Ricciardi MJ, Timenetsky M do CST, Goulart R, Correia CA, Marmorato MP, Ferrari L, Kalil Filho JE, Kallas EG. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fimmu.2022.908398 -
Vancouver
Silveira CGT, Magnani DM, Costa PR, Silva VHIA da, Ricciardi MJ, Timenetsky M do CST, Goulart R, Correia CA, Marmorato MP, Ferrari L, Kalil Filho JE, Kallas EG. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fimmu.2022.908398 - Immune effects ofLactobacillus caseiShirota in treated HIV-infected patients with poor CD4+T-cell recovery
- Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection
- Invariant natural killer T cells in patients with common variable immunodeficiency [Carta]
- CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children
- Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine
- CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis
- Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
- Predictors of mortality in patients with yellow fever: an observational cohort study
- IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID
- Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
Informações sobre o DOI: 10.3389/fimmu.2022.908398 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
